17-11-14　ⓔ文献

  1. Sadler JE, Mannucci PM, et al: Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost, 2000; 84: 160–174.

  2. Meyer D, Fressinaud E, et al: Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. Thromb Haemost, 1997; 78: 451–456.

  3. Zhang ZP, Falk G, et al: A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish vWD type III patients. Hum Mol Genet, 1992; 1: 767–768.

  4. The National Heart, Lung, and Blood Institute: The Diagnosis, Evaluation and Management of Von Willebrand Disease. National Institutes of Health Publication No.08-5832. 2007.

  5. Michiels JJ, Gadisseur A, et al: Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3. Semin Thromb Hemost, 2006; 32: 636–645.